LexDanaLexDanabeta
Inventor

Barry Victor Lloyd Potter

Inventor
Bath, GB

Overview

54→
Patents
1997–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 54 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%
A61KPreparations for medical, dental or toiletry purposes23%
C07DHeterocyclic compounds23%
C07JSteroids18%
C07CAcyclic or carbocyclic compounds2%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms1%
G06FElectric digital data processing1%
Y02ATechnologies for adaptation to climate change1%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests1%
Y10TTechnical subjects covered by former us classification1%
PatentTitleYear
11,030,117Protecting host memory from access by untrusted accelerators20218,846,737'Compound'20148,691,281'Solid pharmaceutical composition containing 6-oxo-6,7,8,9,10,11-hexahydrocyclohepta (C)chromen-3-yl sulfamate and polymorphs thereof'20148,558,028'Compound capable of inhibiting 17-beta hydroxysteriod dehydrogenase'20138,470,860'Phenyl-sulfamates as aromatase inhibitors'20138,394,825'Compound'20138,207,152'Methods for treating or preventing cancer by preventing, inhibiting, or arresting cell cycling'20128,148,415'Sulfamic acid ester compounds useful in the inhibition of steroid sulphatase activity and aromatase activity'20128,124,614'Steroidal compounds for inhibiting steroid sulphatase'20128,119,627'Heterocyclic compounds as inhibitors of 17beta-HSD3'20128,093,279'Compound'20128,030,296'Oestrogen-17-sulphamates as inhibitors of steroid sulphatase'20118,022,224'1,2,4-triazol-1-yl bisphenyl derivatives for use in the treatment of endocrine-dependent tumors'20118,003,783'17B-hydroxysteroid dehydrogenase inhibitors'20117,968,561'Steroidal compounds as steroid sulphatase inhibitors'20117,893,284'Oestrogen derivatives as inhibitors of steroid sulphatase'20117,846,965'Compound'20107,786,152'Compound'20107,745,472'Compound'20107,361,677'Polycyclic sulphamate compounds suitable for use as inhibitors of aromatase and/or sulphatase'20087,335,650'Composition'20087,309,715'Compound'20077,276,513'Steroidal compounds for inhibiting steroid sulphatase'20077,230,020'11β-hydroxysteroid dehydrogenase inhibitors'20077,211,246'Compositions comprising oestrone-3-0-sulphamate and trail (TNF-related apoptosis inducing ligand)'20077,202,272'Compound'20077,129,269'Compound'20067,119,081'Oestrogen-17-sulphamates as inhibitors of steroid sulphatase'20067,098,199'Steroid sulphatase inhibitors'20067,098,343'Compound'20067,098,218'Steroidal compounds for inhibiting steroid sulphatase'20067,078,395'Methods for treating or preventing cancer by preventing, inhibiting or arresting cell cycling'20067,067,503'17-aryl linker derivatised estrogen 3-sulphamates as inhibitors of steroid sulphatase'20066,949,561'Steroid 3-O-sulphamate derivatives as inhibitors of oestrone sulphatase'20056,921,776'Compound'20056,903,084'Steroid sulphatase inhibitors'20056,858,597'Halogenated sulphamate-, phosphonate-, thiophosphonate-, sulphonate- and sulphonamide- compounds as inhibitors of steroid sulphatase'20056,676,934'Pharmaceutical composition with tumor necrosis factor A and 2-methoxyestrone-3-0-sulphamate for inhibition of estrone sulphatase'20046,670,353'Oxime-group containing oestrone sulphatase inhibitors'20036,653,298'Composition'20036,642,397'Steroid sulphatase inhibitors'20036,642,220'Compounds that inhibit oestrone sulphatase; compositions thereof; and methods employing the same'20036,506,792'Compounds that inhibit oestrone sulphatase and/or aromatase and methods for making and using'20036,476,011'Methods for introducing an estrogenic compound'20026,239,169'Non-steroidal polycyclic ring sulphamate derivatives, their preparation and their use as oestrone sulphatase inhibitors'20016,187,766'Steroid sulphatase inhibitors'20016,159,960'Steroid sulphatase inhibitors'20006,083,978'Compounds with a sulfamate group'20006,017,904'Steroid sulphatase inhibitors'20006,011,024'Steroid sulphatase inhibitors'20005,861,390'Steroid sulphatase inhibitors'19995,830,886'Steroid sulphatase inhibitors'19985,616,574'Steroid sulphatase inhibitors'19975,604,215'Steroid sulphatase inhibitors'1997

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1997–2014Based in Bath, GB· patent location history
1997–2010Based in Bathford, GB· patent location history
2000–2014Patents assigned to STERIX LTD (46)· patent assignee history
2000–2006Based in Avon, GB· patent location history
2003–2011Based in Oxford, GB· patent location history
2010–2014Based in Slough, GB· patent location history
2012–2014Patents assigned to POTTER BARRY VICTOR LLOYD (10)· patent assignee history
2012–2014Patents assigned to PUROHIT ATUL (7)· patent assignee history
2012–2013Patents assigned to REED MICHAEL JOHN (6)· patent assignee history
2012–2014Patents assigned to WOO LOK WAI LAWRENCE (6)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
STERIX LTD462000–2014
POTTER BARRY VICTOR LLOYDself102012–2014
PUROHIT ATUL72012–2014
REED MICHAEL JOHN62012–2013
WOO LOK WAI LAWRENCE62012–2014
Locations
LocationPatentsSpan
Bath, GB171997–2014
Slough, GB142010–2014
Oxford, GB122003–2011
Avon, GB52000–2006
Bathford, GB41997–2010